Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Boehringer Ingelheim
Washington University School of Medicine
Seagen Inc.
Eli Lilly and Company
Pfizer
Pfizer
Tomsk National Research Medical Center of the Russian Academy of Sciences
M.D. Anderson Cancer Center
Institute of Cancer Research, United Kingdom
Eisai Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eisai Inc.
Arcus Biosciences, Inc.
Replimune Inc.
Arcus Biosciences, Inc.
Erasca, Inc.
Incyte Corporation
Genentech, Inc.
USWM, LLC (dba US WorldMeds)
Poseida Therapeutics, Inc.
Novartis
Jonsson Comprehensive Cancer Center
City of Hope Medical Center
Genentech, Inc.
Astellas Pharma Inc
M.D. Anderson Cancer Center
City of Hope Medical Center
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Seagen Inc.
Baylor College of Medicine
AbbVie
Pfizer
M.D. Anderson Cancer Center
TORL Biotherapeutics, LLC
HonorHealth Research Institute
Seagen Inc.
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
University of Washington
Abramson Cancer Center at Penn Medicine
AgonOx, Inc.
Peking University Cancer Hospital & Institute